Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome. (Q54351759)

28 May 2018

title

Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome. (English)

1 reference

28 May 2018

1 reference

Yasuyo Kashiwagi

1

1 reference

28 May 2018

Hisashi Kawashima

2

1 reference

28 May 2018

Shigeo Nishimata

3

1 reference

28 May 2018

Ryuhei Nagao

4

1 reference

28 May 2018

Kiyoko Watanabe

5

1 reference

28 May 2018

Kouji Takekuma

6

1 reference

28 May 2018

Akinori Hoshika

7

1 reference

28 May 2018

publication date

22 September 2007

1 reference

28 May 2018

published in

Clinical Rheumatology

1 reference

28 May 2018

volume

27

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

277-279

1 reference

28 May 2018

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

cites work

1 reference

12 December 2020

Anakinra in mutation-negative CINCA syndrome

1 reference

12 December 2020

Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene

1 reference

12 December 2020

Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome

1 reference

12 December 2020

Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel

1 reference

12 December 2020

Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease

1 reference

12 December 2020

A case report of neonatal onset multisystemic inflammatory disease in Japan treated with continuous hemodiafiltration and steroid pulse therapy.

1 reference

12 December 2020

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

1 reference

12 December 2020

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

1 reference

12 December 2020

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

1 reference

12 December 2020

A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents

1 reference

12 December 2020

Syndrome for diagnosis: dwarfing, persistently open fontanelle; recurrent meningitis; recurrent subdural effusions with temporary alternate-sided hemiplegia; high-tone deafness; visual defect with pseudopapilloedema; slowing intellectual development

1 reference

12 December 2020

A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy

1 reference

12 December 2020

Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS)

1 reference

12 December 2020

10.1007/S10067-007-0734-7

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018